Skip to main content

Table 3 Calculated IC50 and selectivity index values for Amy and Sor against HepG2 and WI-38 cell lines

From: Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death

Treatment

IC50

Selectivity Index (SI)

HepG2

WI-38

Amygdalin (mg/ml)

5.21 ± 0.09

141.25 ± 0.23

27.1

Sorafenib (µM)

2.21 ± 0.06

0.59 ± 0.002

0.27